Scientists have sequenced and annotated the first complete mitochondrial genome of Anopheles funestus, one of the main vectors of malaria in sub-Saharan Africa.
The drug - called tafenoquine - prevents malaria relapses by about 70 percent, clinical studies have shown.
Scientists are racing to stamp out the disease in southeast Asia before unstoppable strains spread.
Krintafel is the first new treatment for P. vivax malaria in more than 60 years.
Plasmodium species produce an ortholog of the cytokine macrophage migration inhibitory factor, PMIF, which modulates the host inflammatory response to malaria. Using a novel RNA replicon-based vaccine, researchers showed the impact of PMIF immunoneutralization on the host response.
A Johns Hopkins team devised a plan to distribute insecticide-treated bed nets annually to children in schools.
Scientists have taken a significant step toward developing a new vaccine for malaria, revealing for the first time an 'atomic-scale' blueprint of how the parasite invades human cells.
Next month, London scientists will begin stitching bits of DNA together and inserting them into hundreds of insect eggs - the first step toward engineering a new kind of mosquito that could help eradicate malaria.
Using two experimental anti-malarial vaccines, which work in different ways, can greatly reduce the number of malaria infections in animal studies.
The World Health Organization (WHO) certified Paraguay as having eliminated malaria, the first country in the Americas to be granted this status since Cuba in 1973.